Samrat Pharmachem Ltd

NSE: SAMRATPH · BSE: 530125 · Pharmaceuticals & Biotechnology · 15 announcements

Share price: ₹239.05
Market cap: ₹73.86 Cr
Revenue (annual): ₹289.7 Cr
Net profit (annual): ₹-3.31 Cr
P/E (TTM): -33.5×Sector 47.4×
Promoter holding: 49.09%+0.00% QoQ
FII holding: 3.24%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Financial Results 4 Board Meeting Date 2 Annual General Meeting 2 Debt & Borrowing 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

7 Apr 2026 15:01 IST BSE

Debt & Borrowing

Samrat Pharmachem Debt & Borrowing

Samrat Pharmachem Limited filed its initial disclosure under the SEBI Large Corporate framework for the financial year. The company confirmed it does not meet the criteria to be identified as a Large Corporate, reporting zero outstanding borrowings as of March 31.

Read the filing ↗